Form 4: Clene Inc. Director Jacobovitz Shalom Acquires Stock Options
SEC Form 4
Director Jacobovitz Shalom acquired stock options for 3,806 shares of Clene Inc. common stock on October 2, 2024.
Summary
- On October 2, 2024, Jacobovitz Shalom, a director of Clene Inc., was granted stock options to purchase 3,806 shares of the company's common stock.
- The exercise price for these options is $4.89 per share.
- The options were granted under the Clene Inc. Amended 2020 Stock Plan and vest immediately.
- The options expire on October 1, 2034.
Sentiment
Score: 6
Explanation: The granting of stock options is a neutral event, reflecting standard compensation practices. It suggests confidence in the company's future, but doesn't provide strong positive or negative signals.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, aligning the interests of management with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of stock option grant |
| 10/01/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.